diabetes therapies Flashcards

1
Q

what is A1C ?

A

series of minor hemoglobin components that are formed slowly and non enzymaticall
from Hgb and glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is proportional to the rate of formation for A1C

A

proportional to glucose concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do we use A1C for?

A
  • predicts the risk for complications

- glycemic history for 2-3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what do these : GSA and GSP stand for ?

when do we use?

A
  • glycosylated serum albumin
  • glycosylated total serum proteins
  • use when A1C cant be measures OR hemolytic anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the A1C targets for:

0) normal, no diabetes
1) adults with t2dm if at low risk for hypos
2) most adults with T1 or T2
3) functionally dependent, recurrect hypo, limited life, frail, elder
4) end of life

A

0) 5.4-5.7
1) less than or equal to 6.5
2) less than or equal to 7
3) 7.1-8.0=for functionally dependent, 7.1-8.5= other
4) end of life: A1C not recommended.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When explaining A1C to patients, what is important for them to know?

A

that they A1C value is NOT the blood glucose value that you see on the machine
7% is BG of 9.5
12% is BG of 19.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

if you want to achieve an A1C of less than or equal to 7, for most patients, what should be there preprandial BG and they 2hPP?

A

PRE: 4.0-7.0 mmol/L
post: 5.0-10 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

name 5 factors that can affect A1C

A

1) anemia – increases A1C if there is B12 or Fe def.
2) altered hemoglobin
3) altered glycation - increases A1C if there is chronic renal failure and erythrocyte ph that decreases
4) erythrocyte destruction - splenectomy increases A1C
5) assays- hyperbilirubinermia, ETHOH and chronic opiates increases A1C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the pediatric glycemic targets? and why

A

A1c: less than or equal to 7.5
FBG: 4-8
2hPP: 5-10
why: caution needed to minimize hypoglycemias. and accept higher targets if children or ados have frequent hypos.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name three ways to measure plasma glucose

A

1) blood glucose meter
2) CGM
3) flash glucose monitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is ambulatory glucose profile ?

A

ABG: average of the 7 days of a CGM or flash one.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are different CGM targets for :

1) T1/T2
2) obese T1/T2
3) Pregnancy T1
4) Pregnancy gestational or t2

A

1) more than 70% (70-180 mg/ml)
2) more than 50% (70-180 mg/ml)
3) more than 70% (62-140 mg/ml)
4) more info needed to get a target range BUT we want to be on target for a majority of time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the initail choice of therapy if the target is 7 and :

1) A1C is less than 1.5% over target
2) A1C more than 1.5% over target

A

1) start with behaviour and eating changed and if not on target in 3mo start metformin OR start metformin with the eating behaviours
2) start metformin with healthy behaviour interventions AND consider second agent as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name the function of Biguanides.

Name 3 benefits and 3 risks.

A

-it is to improve insulin sensitivity, and decrease neogluconeogenesis

  • negligible risk as monotherapy, no weight gain and improved CV outcomes in OW patients
  • GI side effects, B12 deficiency, creatinine clearance: contraindicated if hepatic failure.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What type of medication is metformin.

Name a

A

Biguanide

like glucophase or glumetza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name the function of Insulin secretagogues .

Name 3 benefits and 3 risks.

A
  • stimulate pancreatic insulin prod.
  • rapid onset of response, decreases microvascular risks and 0.7-0.8% reduction
  • all associated with risk of hypoglycemia.
  • weight gain!-esp glyburide
  • only taken prior to meals and not at bed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What type of medication is Sulfonureas and Meglitinides?

Name some ex

A

insulin secretagogues

sulf: gliclazide, glyburide
meg: repagliide

18
Q

Name the function of alpha-glucosidase inhibitors .

Name 3 benefits and 3 risks.

A

delay the glucose absorption and delays gastric emptying

  • reduce PP glucose, in pt with prediabetes there is 50% reduction of CV events and weight neutral
  • GI side effects, TID dosing, CI: DKA and IBD
19
Q

What type of medication is Acarbose

Name some ex

A

Alpha-glucosidase inhibitor

name for acarbose is glucobay

20
Q

Name the function of Thiazolidinediones (TZD) .

Name 3 benefits and 3 risks.

A
  • increase insulin sensitivity
  • longer duration of glycemic control with monotherapy
    cardio benefits like increases HDL, lowers TG and CVD events
  • weight gain and water retention( edema and or CHF) risk of fractures and bladder cancer and CI for liver dysfunction and known heart failure
21
Q

What type of medication is Pioglitazone and Rosiglitazone

Name some ex

A

TZDs

pio: Actos
rosi: Avandia

22
Q

What is GLP-1 ?

what are the three systems it affects?

A
  • a gut hormone that is released in response to nutrient digestion
  • peripherally, CNS and Pancreas
23
Q

How does GLP-1 influence the body peripherally?

A

affects gut motility,
inhibits gastric acid secretion and
inhibits glucagon secretion

24
Q

How does GLP-1 influence CNS ?

A

it induces satiety, leading to reduced weight gain

25
Q

How does GLP-1 influence the pancreas?

A

it induces the expansion of insulin secreting beta cell mass
increases glucose-stimulated insulin secretion

26
Q

what is the role of DPP-4?

A

it inhibits GLP-1 and blocking this effect means that there will be more glp-1 in the blood stream

27
Q

Name the function of DPP-4 inhibitors .

Name 3 benefits and 3 risks.

A
  • stimulate insulin secretion and inhibit glucagon production
  • weight neutral, neutral CV studies and well tolerates and reduces PPG. no risk of hypos
  • headaches, rare cases of pancreatitis and sometimes cardiac insufficiency
28
Q

What type of medication is sitagliiptin, saxagliptin, linagliptin and alogliptine ? Name some ex
what is ex of combo DPP4i + biguaides?

A

DPP4inhibitors
januvia, onglyzia, trajenta, nesina

the combo are janumet, jentadueto …

29
Q

Name the function of incretins like GLP1 agonist .

Name 3 benefits and 3 risks.

A

they delay gastric emptying, reduce appetite, stimulate glucose dependent insulin production and inhibit glucagon

  • reduce PPG, significatn weight loss, liraglutide decreases CV events, no hypo risk
  • GI side effects, nausea, parafollicular cell hyperplasia
30
Q

what type of medication is semaglutide, exanatide, liraglutide and dulaglutide ?

A

they are incretins- GLP1-agonist

31
Q

Name the function of Sodium glucose Co-transporter-2 (SGLT2)inhibitors .
comment on some benefits and side effects

A
  • decrease glucose renal reabsorption and increases glucose excretion
  • weight loss good
  • 0.7-1% reduction of A1C!
  • slower progression of kidney disease
  • protective CV effect
    bad: euglycemic ketoacidosis, frequent UTIs, hypovolemia
32
Q

what are some common combos for medications

A
  • DPP4i + SGLT2i
  • SGLT2i+ biguanide
  • long acting insulin + GLP1-RA
33
Q

when is the onset of bolus, rapid acting insulin ?
when do you inject?
peak? and duration?

A

-between 10-15 min
and faster acting insulin aspart is 4 min
-0-15 min before meal or -1-2 min for the aspart
-1-1.5 h
-3-5h

34
Q

what is the onset of Bolus, short acting insulin (clear)?
peak?
duration?
when to inject?

A
  • 30 min or 15 for U500
  • 2-3 h or 4-8
  • 6.5 h or 17-24
  • 30 min before meal
35
Q

what is the onset of basal insulin, INTERMEDIATE-ACTING (cloudy) like Humalin?
peak?
duration?
when to inject?

A
  • 1-3h
  • 5-8
  • up to 18
  • morning and/or night
36
Q

what is the onset of long acting insulin (clear) like lantus, toujeo, tresiba, basaglar, levemir ?
peak?
duration?
when to inject?

A
  • 90 min
  • no applicable–its long lasting
  • ranges between 16 and 30 hours
  • morning and or night, no less than 8 hours between injections
37
Q

what is active insulin?

A

it is not bolus, there is insulin that will be working for hours after injection.

38
Q

how much active insulin is there in %, after 1h,2h and 3h?

A
  • 70,
  • 40
  • 10
39
Q

what is the last resort treatment for diabetes patients?

A

transplants of the pancreas or of the islets

40
Q

what do transplants do?

A

they restore the endogenous insulin secretion
the pancreatic may improve microvascular outcomes, lipids, BP, and carotid thickness.
islet transplants may stabilize the microvascular disease